Navigation Links
Tuberculosis drug shows promise against latent bacteria
Date:9/12/2008

A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.

Despite numerous treatment advances, tuberculosis (TB) remains a serious disease fueled by co-infection of HIV patients, the rise of drug-resistant strains, and the ability of Mycobacterium tuberculosis to become dormant and linger in the lungs. In fact, one third of the world population is infected, asymptomatically, with latent TB and is at risk of developing active TB disease during their life time.

Anil Koul and colleagues at Johnson & Johnson tested R207910 on dormant M. tuberculosis in three different laboratory models of latency. R207910 targets a protein (ATP synthase) essential for making cellular energy (ATP) in actively replicating TB. The researchers reasoned that even dormant bacteria, which are essentially physiologically "turned off", still need to produce small quantities of ATP to survive. As such, a block in ATP synthesis might be an Achilles heel for killing dormant bacteria.

This reasoning proved to be correct and R207190 was able to kill dormant bacteria by greater than 95% whereas current drugs like isoniazid had no effect. Surprisingly, they found that R207910 is slightly more effective in killing dormant bacteria as compared to actively replicating ones, a unique spin as all known TB drugs are more effective on replicating bugs. Koul and colleagues hope to validate these results clinically, and note that ATP synthase should be looked at as a drug target for other persistent bacterial infections.


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Preventing tuberculosis reactivation
2. Cornell researcher seeks clues to how tuberculosis infects cells
3. New drug targets may fight tuberculosis and other bacterial infections in novel way
4. Vitamin E may increase tuberculosis risk in male smokers with high vitamin C intake
5. Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment
6. Excavated Jericho bones may help Israeli-Palestinian-German team combat tuberculosis
7. Potential new drug target to fight tuberculosis identified
8. Clinical trial for new tuberculosis vaccine
9. Research shows skeleton to be endocrine organ
10. Clones on task serve greater good, evolutionary study shows
11. Study shows link between alcohol consumption and hiv disease progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... months ended December 31, 2016. SQI is ... company that develops and commercializes proprietary technologies and products for ... ... milestones achieved in fiscal 2016," said Andrew Morris , ...
(Date:2/21/2017)... ... February 21, 2017 , ... Cancer ... Heritage has joined its executive team to lead the development and commercialization of ... to help improve the diagnosis and treatment of cancer. The CIDT addresses the ...
(Date:2/21/2017)... ... February 21, 2017 , ... Creation Technologies, a ... for original equipment manufacturers (OEMs) , today announced it has received the ‘Highest ... year winning in its category of electronics manufacturing services (EMS) providers with annual ...
(Date:2/21/2017)... -- Scientists From Two Companies to Accelerate ... ... STEER, creator of advanced materials platform technologies that ... plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced ... technology company, on creating co-rotating twin screw extruder technology ...
Breaking Biology Technology: